Skip to main content
Clinical Trials/CTRI/2022/11/047161
CTRI/2022/11/047161
Recruiting
未知

An evaluation of antimicrobial use and prescribing practices in ICUs in IRIS.

The George Institue for Global Health India0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: Z163- Resistance to other antimicrobialdrugs
Sponsor
The George Institue for Global Health India
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
The George Institue for Global Health India

Eligibility Criteria

Inclusion Criteria

  • Invitation to participate will be open to all intensive care units within the participating hospitals of the IRIS network. Participation from a minimum of 4 and a maximum of 8 ICUs is sought. These are a mix of public, private and mixed setting hospitals, representative of all sectors catering to critical care in India.

Exclusion Criteria

  • ICUs which have established registry data collection of core, and daily Q (including quality indicators) to a completeness of \>95% compliance will be selected.

Outcomes

Primary Outcomes

Not specified

Similar Trials